Delivery Order SPE2DB22D3102-SPE2DB25FL2RS
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Adenosine 12 mg/4 mL syringes with a ceiling value of $1,183.83. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 13,...
- The Defense Logistics Agency awarded a delivery order valued at $3,091.99 to AmerisourceBergen Drug Corp for the supply of Adenosine 12 mg/4 mL syringes on August 22, 2025, with completion expected by August 25, 2025. This firm fixed-price delivery order is being fulfilled from the company's place of performance in Conshohocken, Pennsylvania, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adenosine 12mg/4ml (10 units) on August 21, 2025. This firm fixed price delivery order, valued at $2,154.70, represents a competitively awarded, non-set-aside contract with a place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Adenosine 12 mg/4 mL vials with a ceiling value of $1,084.19. This is a firm fixed-price delivery order with an ultimate completion date of July 21, 2025, and no set-aside designation was used in the award. The work will be performed at the vendor's location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $1,136.88 delivery order to AmerisourceBergen Drug Corp for the supply of Adenosine 12 mg/4 mL vials on July 18, 2025, with completion targeted for July 21, 2025. The award utilizes firm fixed pricing with no set-aside designation, indicating competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Adenosine Injection with a ceiling value of $1,425.10 under firm fixed-price terms. The contract, which was competitively awarded without set-aside provisions, is effective through August 23, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a continuation of AmerisourceBergen's substantial pharmaceutical...
- This delivery order, valued at $3,878.46, awards AmerisourceBergen Drug Corp the supply of Adenosine 12mg/4mL in quantities of 10 units for the Defense Logistics Agency's Medical Supply Chain. The contract was competitively awarded without any set-aside designation on August 21, 2025, with the same date serving as the ultimate completion deadline. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency Troop Support Medical awarded a $1,975.93 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561854162 ! ADENOSINE 12 MG/4 ML SYRINGE 4ML. Place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The delivery order is for the purchase of adenosine injection syringes and has a period of performance from August 18-21, 2023. As a major supplier of pharmaceuticals and medical supplies, Amerisourcebergen will fulfill...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply Adenosine 12 mg/4 ml syringes. The contract has a potential value of $1,701.42 and a period of performance through January 26, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors identified. This delivery order is issued under a larger indefinite delivery contract...
- The Defense Logistics Agency Troop Support Medical awarded a $210,520 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561940446! Adenosine Injection. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the requested pharmaceutical product to the agency's location in Conshohocken, Pennsylvania within the one day period of performance between August 15-16, 2023. The delivery order was issued under an existing Amerisourcebergen Corporation...
- SPE2DB22D3102Indefinite Delivery Contract
- SPE2DB22D3102-SPE2DB25FL2RSDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,292.82 to AmerisourceBergen Drug Corp for the supply of Adenosine 12 mg/4 mL syringes on August 21, 2025, with completion scheduled for August 22, 2025. This contract, which carries no set-aside designation, was competitively awarded on a firm fixed-price basis and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a continuation of pharmaceutical supply support under AmerisourceBergen's broader federal contract portfolio with DLA. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion vehicle running through December 2026 that serves as the primary pharmaceutical supply mechanism for military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen maintains extensive capabilities to supply a comprehensive range of medications, medical devices, and healthcare commodities across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The current adenosine order fulfills immediate medical supply requirements within this established framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 8/21/25 |